Direct cell-to-cell spread of a pathogenic yeast.
BACKGROUND
Cryptococcosis, a fatal fungal infection of the central nervous system, is one of the major killers of AIDS patients and other immunocompromised hosts. The causative agent, Cryptococcus neoformans, has a remarkable ability to 'hide' and proliferate within phagocytic cells of the human immune system. This intracellular phase is thought to underlie the ability of the pathogen to remain latent for long periods of time within infected individuals.


RESULTS
We now report that Cryptococcus is able to undergo 'lateral transfer' between phagocytes, moving directly from infected to uninfected macrophages. This novel process was observed in both C. neoformans serotypes (A and D) and occurs in both immortalised cell lines and in primary human macrophages. Lateral transfer is independent of the initial route of uptake, since both serum-opsonised and antibody-opsonised C. neoformans are able to undergo direct cell-to-cell transfer.


CONCLUSIONS
We provide the first evidence for lateral transfer of a human fungal pathogen. This rare event may occur repeatedly during latent cryptococcal infections, thereby allowing the pathogen to remain concealed from the immune system and protecting it from exposure to antifungal agents.
Ma
Hansong
H
Molecular Pathobiology, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK. hsm142@gmail.com <hsm142@gmail.com>
Croudace
Joanne E
JE
Lammas
David A
DA
May
Robin C
RC
D000818:Animals; D002460:Cell Line; D002465:Cell Movement / Q000276:immunology; D002478:Cells, Cultured; D003453:Cryptococcosis / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D003455:Cryptococcus neoformans / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D008264:Macrophages / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D051379:Mice; D010587:Phagocytosis / Q000276:immunology
Infect Immun. 1999 Feb;67(2):885-90
9916104
Infect Immun. 1998 Sep;66(9):4461-8
9712801
J Clin Microbiol. 1999 Oct;37(10):3204-9
10488178
Nat Rev Microbiol. 2005 Oct;3(10):753-64
16132036
J Cell Physiol. 2006 Nov;209(2):288-96
16826602
Curr Biol. 2006 Nov 7;16(21):2156-60
17084701
Curr Biol. 2006 Nov 7;16(21):2161-5
17084702
BMC Immunol. 2007;8:16
17705844
Infect Immun. 2000 Jul;68(7):4225-37
10858240
Microbes Infect. 2000 Nov;2(13):1609-18
11113380
J Virol. 2002 Jan;76(1):1-8
11739666
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3165-70
11880650
J Infect Dis. 2002 Aug 15;186(4):522-30
12195380
J Clin Invest. 2003 Oct;112(7):1080-94
14523045
Infect Immun. 2004 Sep;72(9):4985-95
15321990
J Cell Biol. 1989 Oct;109(4 Pt 1):1597-608
2507553
Clin Exp Immunol. 1995 Jan;99(1):82-9
7813114
Infect Immun. 1999 Jul;67(7):3512-7
10377133